Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Wilby

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Expert Review of Anticancer Therapy|December 4, 2009
Role and rationale of gene therapy and other novel therapies in the management of NMIBCCarlos Lojo Rial, Daniel Wilby, Prasanna Sooriakumaran
BJU International|April 25, 2009
What would truly patient-centred urological care look like?Martin Nuttall, Daniel Wilby, Barnaby Chappell, et al.
World Journal of Urology|March 5, 2009
Bladder cancer: new TUR techniquesDaniel Wilby, Kay Thomas, Eleanor Ray, et al.
Clinical Anatomy (New York, N.Y.)|March 12, 2014
Continence and micturition: an anatomical basisAdarsh P Shah, Amit Mevcha, Daniel Wilby, et al.
Clinical Medicine Insights. Oncology|May 8, 2025
Magnetic Resonance or Computed Tomography and Bone Scan for Staging Metastatic Hormone-Sensitive Prostate CancerMona Ali Hassan, Shobana Anpalakhan, Marina Campione, et al.
European Urology|August 23, 2022
Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled TrialWei Shen Tan, Aaron Prendergast, Charlotte Ackerman, et al.
European Urology Open Science|January 18, 2021
Major Urological Cancer Surgery for Patients is Safe and Surgical Training Should Be Encouraged During the COVID-19 Pandemic: A Multicentre Analysis of 30-day OutcomesWei Shen Tan, Rajan Arianayagam, Pramit Khetrapal, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
A Multicenter Study of 2-year Outcomes Following Hyperthermia Therapy with Mitomycin C in Treating Non-Muscle Invasive Bladder Cancer: HIVEC-EWei Phin Tan, Ana Plata Bello, Carlos Garcia Alvarez, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Expert Review of Anticancer Therapy|December 4, 2009
Role and rationale of gene therapy and other novel therapies in the management of NMIBCCarlos Lojo Rial, Daniel Wilby, Prasanna Sooriakumaran
BJU International|April 25, 2009
What would truly patient-centred urological care look like?Martin Nuttall, Daniel Wilby, Barnaby Chappell, et al.
World Journal of Urology|March 5, 2009
Bladder cancer: new TUR techniquesDaniel Wilby, Kay Thomas, Eleanor Ray, et al.
Clinical Anatomy (New York, N.Y.)|March 12, 2014
Continence and micturition: an anatomical basisAdarsh P Shah, Amit Mevcha, Daniel Wilby, et al.
Clinical Medicine Insights. Oncology|May 8, 2025
Magnetic Resonance or Computed Tomography and Bone Scan for Staging Metastatic Hormone-Sensitive Prostate CancerMona Ali Hassan, Shobana Anpalakhan, Marina Campione, et al.
European Urology|August 23, 2022
Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled TrialWei Shen Tan, Aaron Prendergast, Charlotte Ackerman, et al.
European Urology Open Science|January 18, 2021
Major Urological Cancer Surgery for Patients is Safe and Surgical Training Should Be Encouraged During the COVID-19 Pandemic: A Multicentre Analysis of 30-day OutcomesWei Shen Tan, Rajan Arianayagam, Pramit Khetrapal, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
A Multicenter Study of 2-year Outcomes Following Hyperthermia Therapy with Mitomycin C in Treating Non-Muscle Invasive Bladder Cancer: HIVEC-EWei Phin Tan, Ana Plata Bello, Carlos Garcia Alvarez, et al.
Pageof 1